Accelerate AMI Diagnostic Decisions: Efficiency Advantages of reOpenTest Cardiac Marker Panel
Time is myocardium! Every minute counts. Learn how our triad cardiac marker (cTnI/Myo/CK-MB) panel provides more comprehensive myocardial injury information through a single test, helping key customers such as emergency departments significantly improve the diagnostic efficiency of acute myocardial infarction (AMI), saving valuable time for life.
Get a quote for the cardiac marker panel productChallenges in Rapid AMI Diagnosis and the Value of Panel Testing
Rapid and accurate diagnosis of acute myocardial infarction (AMI) is key to initiating timely reperfusion therapy and saving lives. However, single cardiac marker testing has limitations: early markers (such as myoglobin Myo) rise rapidly but lack specificity, while highly specific markers (such as cardiac troponin cTnI) appear later. Relying on multiple single tests is not only time-consuming, but may also delay the best treatment time and increase the workload of the emergency department.
More comprehensive myocardial injury information
Our panel combines markers that reflect different stages of injury: early (Myo), intermediate (CK-MB), and late (cTnI). A single test captures the dynamic changes of myocardial injury in its entirety, providing a more reliable basis for diagnosis.
Significantly reduce diagnosis time
No need to wait for multiple rounds of single test results. By obtaining multiple key indicators at once, the reOpenTest panel can shorten the diagnosis time to within 15 minutes, greatly accelerating the clinical decision-making process and truly buying time to save lives.
Optimize emergency workflow
Reduce the number of sample processing, testing rounds, and result waiting time, effectively simplify the workflow in emergency departments and POCT environments, reduce operational complexity, and improve overall diagnosis and treatment efficiency and resource utilization.
Core Advantages of reOpenTest Cardiac Marker Panel
Optimized marker combination
We offer the clinically widely recognized "triad cardiac marker" (cTnI/Myo/CK-MB) panel, as well as other efficient combinations customized according to clinical needs, to fully meet the needs of different diagnostic strategies and comply with relevant clinical guideline recommendations.
High sensitivity and specificity
Based on reOpenTest's mature technology platform and strict quality control system, we ensure that each marker test achieves excellent sensitivity and specificity, providing clinicians with highly reliable diagnostic results.
Get results quickly in 15 minutes
Using advanced immunochromatography technology, accurate test results can be provided within 15 minutes, fully meeting the stringent requirements of emergency departments, chest pain centers and other scenarios for rapid diagnosis.
Perfectly adapted to point-of-care testing (POCT)
The operation process is simple and convenient, without the need for large-scale professional equipment or complex operation training, and can be quickly deployed and applied in a variety of point-of-care testing scenarios such as emergency rooms, ambulances, and community clinics.
Our cardiac marker panel products
Cardiac Triad Combined Assay Reagent (cTnI/Myo/CK-MB)
The classic gold combination for early AMI diagnosis, a single test provides comprehensive dynamic information on myocardial injury to help with rapid and accurate clinical decisions.
Learn moreCardiac Troponin I (cTnI) Rapid Test Kit (Whole Blood/Serum/Plasma)
An immunochromatographic rapid test tool for the qualitative detection of cardiac troponin I (cTnI), suitable for whole blood, serum or plasma samples. It can be used for the early auxiliary diagnosis of acute myocardial infarction (AMI). The results are presented quickly in 10–15 minutes, the operation is simple, and the results are sensitive and reliable.
Learn moreEmpowering Distributors: How to Promote the Efficiency Advantages of Cardiac Marker Panels to Customers Such as Emergency Departments?
- Highlight time value: Emphasize the rapid testing and decision-making advantages of the reOpenTest panel within the AMI golden treatment "time window," directly relating to patient prognosis.
- Compare single test limitations: Clearly explain the significant advantages of panel testing compared to single tests in providing comprehensive myocardial injury information, avoiding missed and misdiagnoses, and shortening overall diagnosis time.
- Showcase hard data: Provide the product's high sensitivity, high specificity clinical validation data, as well as proof of convenience and stability in POCT scenarios, to build customer trust.
- Compliance with clinical standards: Combine national chest pain center construction standards or related clinical guidelines to illustrate how the reOpenTest panel can help hospitals meet standards and improve diagnosis and treatment levels.
- Emphasize cost-effectiveness: Analyze how panel testing can help hospitals control costs by reducing duplicate testing, optimizing processes, and shortening hospital stays.
Win the emergency market with an efficient cardiac marker panel!
reOpenTest cardiac marker panel reagents are your powerful weapon to open up the emergency market, serve chest pain centers, and improve AMI diagnosis efficiency. We offer competitive products and comprehensive market support. Contact us now for cooperation details.